USACO Corporation Signs Exclusive Distributor Agreement for AI Literature Search Tool Consensus
USACO Corporation (Tokyo) has signed an exclusive distributor agreement with Consensus NLP, Inc. for institutional and group subscriptions to the AI-powered evidence-based research platform Consensus in Japan.
📋 Article Processing Timeline
- 📰 Published: May 20, 2026 at 23:00
- 🔍 Collected: May 20, 2026 at 14:31
- 🤖 AI Analyzed: May 21, 2026 at 08:25 (17h 53m after Collected)
FAQ
What is Consensus?
Consensus is an AI-powered, evidence-based research platform that extracts and summarizes conclusions from over 220 million peer-reviewed research papers, providing answers with links to source publications.
How can institutions in Japan access Consensus?
USACO Corporation has signed an exclusive distributor agreement with Consensus NLP, Inc. for institutional and group subscriptions in Japan. Inquiries can be made through USACO's Consensus product page at https://www.usaco.co.jp/product/detail.html?pdid=505.
What are the key features of Consensus?
Consensus offers three key features: Consensus Meter for visualizing research consensus, Deep Search for reducing literature reviews from days to minutes, and Medical Mode specialized for clinical and biomedical research.
How widely is Consensus used globally?
Consensus has been adopted by over 170 university libraries worldwide and is used by more than 10 million researchers, students, and healthcare professionals.
How does Consensus reduce hallucination risk?
Consensus draws from over 220 million licensed, peer-reviewed research papers and provides answers with direct links to source publications, significantly reducing the hallucination risks associated with general-purpose generative AI.